TY  - JOUR 
AU  - Hernández-Boluda, Juan Carlos
AU  - Pereira, Arturo
AU  - Correa, Juan-Gonzalo
AU  - Álvarez-Larrán, Alberto
AU  - Ferrer-Marín, Francisca
AU  - Raya, José-María
AU  - Martínez López, Joaquín
AU  - Pérez Encinas, Manuel Mateo
AU  - Estrada, Natalia
AU  - Velez, Patricia
AU  - Fox, María-Laura
AU  - García-Gutiérrez, Valentín
AU  - Payer, Ángel
AU  - Kerguelen, Ana
AU  - Cuevas, Beatriz
AU  - Durán, María-Antonia
AU  - Ramírez, María-José
AU  - Gómez-Casares, María-Teresa
AU  - Mata-Vázquez, María-Isabel
AU  - Mora, Elvira
AU  - Martínez-Valverde, C.
AU  - Gómez, Montse
AU  - Cervantes, Francisco
PY  - 2018
UR  - http://hdl.handle.net/20.500.11940/22446
AB  - [EN] Recently, Passamonti et al have developed a new prognostic model to specifically address the prediction of survival in patients with secondary MF, the Myelofibrosis Secondary to PV and ET-Prognostic Model (MYSECPM). It is worth noting that this...
LA  - eng
KW  - Prognosis
KW  - Thrombocythemia, Essential
KW  - Primary Myelofibrosis
KW  - Polycythemia Vera
KW  - Registries
TI  - Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis
DO  - 10.1038/leu.2017.297
T2  - Leukemia
M2  - 553
KW  - CHUS
VL  - 32
ER  -